Ectin Research is managed by a core team of senior professionals from the pharmaceutical industry, clinical physicians and scientists from the academic world in a semi-virtual organization. Where a large network of external complementing competences is consulted when required.

Board of directors

Image for Hans-Peter Ostler

Hans-Peter Ostler

Chairman of the Board

Hans-Peter has more than 20 years of experience from investment banking and private banking e.g. Danske Bank, UBS AG and Swedbank Markets. He is currently the vice chairman for Alligator Bioscience AB, board member of Hoodin AB, Oblique Therapeutics AB, S.P. HMSO Göteborg AB, Promore Pharma AB and InorbitTX AB. Hans-Peter has also extensive previous board experience e.g. as board member of IRLAB Therapeutics AB.

Image for Göran Gannedahl, MD, PhD

Göran Gannedahl, MD, PhD

Board member

Göran has a background as General and Transplant Surgeon. During the last 25+ years Göran has held several senior positions in major pharmaceutical companies, such as Fujisawa, Novartis and AstraZeneca and executive roles in groundbreaking biotech companies. He has experience from therapeutic areas such as Oncology, CV disease, Metabolic disease, Immunology and Lipid disorders.

Image for Christer Edlund, MD, PhD

Christer Edlund, MD, PhD

Board member & co-founder

Christer is Senior Consultant in Urology, working at Kungsbacka Hospital, in Region Halland. Christer has broad cancer therapy experience from treating urology patients for many years and a substantial clinical network.

Image for Marie-Lois Ivarsson, MD, Associate Professor

Marie-Lois Ivarsson, MD, Associate Professor

Board member & co-founder

Marie-Lois is Associate Professor, Department of Surgery, Institute of Clinical Sciences, Sahlgrenska academy, the University of Gothenburg. She has a significant academic network, extensive knowledge within the field of cancer treatment and has taken part in a number of large clinical trials.

Image for Fredrik Andersson

Fredrik Andersson

Board member

Fredrik Has ownership in the company and a strong background in pharmaceutical investment. Co-founded and sat in the board of another life science company.


Image for Anna Sjöblom-Hallén, PhD, MBA

Anna Sjöblom-Hallén, PhD, MBA


Anna is an entrepreneur with extensive experience from her previous work as CEO, and as project manager of different start-ups in the Life Science field where she has managed to create profitable businesses. She has a broad network and knowledge of financing companies, conducting international out-licensing and from heading pharmaceutical development.

Image for Kristofer Svensson

Kristofer Svensson


Kristofer Svensson holds a Bachelor's degree in Economics from Stockholm University. Kristofer has several years of experience from financial executive positions as CFO, primarily within the healthcare sector. Kristofer Svensson has ongoing assignments as CFO at Gabather (publ), Bioextrax AB (publ) and Sinfonia Biotherapeutics. Previous assignment includes CFO at Sensidose (publ) and Melius Pharma AB.

Image for Austin Smith, MD

Austin Smith, MD


Dr. Austin Smith is a Pharmaceutical Physician and Medical Oncologist with a special interest in early phase drug development. He is a graduate of the Royal College of Surgeons, Ireland, and has occupied an extensive range of senior clinical and strategic positions within oncology. These include Vice President for Clinical Development at LINK Medical Research, Medical Director in Early & Experimental Oncology Clinical Development at Theradex Oncology Ltd., Lead Medical Director at PPD and Associate Specialist in Medical Oncology at the London Clinic.

Image for Kevan Cassidy, PhD

Kevan Cassidy, PhD

Director Technical Operations

Kevan Cassidy is a pharmacist, with a PhD in pharmacokinetics and drug metabolism. He has an impressive background from working within the generic industry for many years where he managed formulation development groups, analytical laboratories, clinical program, medical information, pharmacovigilance, and regulatory functions across a number of companies including Consilient Health Ltd, Rosemont Pharmaceuticals, Mylan Inc., and Merck Generics Group Europe.

Partnership opportunities

Ectin Research welcomes established companies in the oncology field in the discussion of potential commercial opportunities using the company’s proprietary technology.

For more information about the company and for the discussion of potential commercial opportunities please contact Anna Sjöblom-Hallén, CEO.